# P9 SUBSTANTIVE RE-AUDIT — LIFE & HEALTH

**Date:** 2026-10-06  
**Baseline:** P8 CLEAN b29f7c8628d2f3b5e171eb184df715d557375643  
**Current candidate:** 3e3b91ea70a9c9bfa8f2072442655acb36234505  
**Status:** SUBSTANTIVE RE-AUDIT — PASS WITH FOLLOW-ON HUMAN VIEW REQUIRED

## Scope

The audit covers all ten selected existing slices: pathology-basics, pharmacology-information-basics, public-health-surveillance-basics, rehabilitation-basics, reproductive-health-information-boundaries, environmental-health-basics, molecular-biology-basics, physiology-of-systems-basics, marine-biology-basics, and environmental-biology-basics.

Eight slices received P9 evidence maturation; public-health-surveillance-basics and environmental-health-basics were intentionally left unchanged because their existing evidence topology was already independently triangulated. No new Claims or slices were introduced by P9.

## Corpus and conformance

- P9 delta: +32 records = 8 Sources + 24 Evidence Use.
- Current corpus: 4457 records / 478 vertical slices / 19 record types.
- Preflight and full Reference, Release Gate and build-and-test CI are green on the current candidate.
- The eight matured slices now use 2 Sources, 3 Claims, 6 Evidence Use, 1 Context and 1 Scope = 13 records each.
- Cross-slice linkage remains 34 Relation records; P9 did not inflate the relation graph.

## Evidence independence and source fit

The eight added sources are institutionally independent official/public references from NCBI, NIGMS, WHO, OpenStax, NOAA and US EPA. The source locators were independently checked against their current public pages.

Source-domain fit is adequate for the intended foundational claims: NCBI covers tissue/cell organization and genome-to-protein mechanisms; NIGMS covers pharmacology as a science and pharmacokinetic/pharmacodynamic concepts; WHO covers rehabilitation and sexual/reproductive health; OpenStax covers homeostasis; NOAA covers ecosystem science; EPA covers ecological condition. These are appropriate reference-level sources, not substitutes for individualized clinical, legal, operational or emergency guidance.

The added Evidence Use records resolve to the intended P9 Claims and added Sources, with an explicit non-individualized applicability boundary. The existing second source in each matured slice remains in the slice, so P9 creates two-source triangulation rather than replacing the baseline source.

## Mechanism/dependency depth

P9 improves evidentiary depth without introducing unsupported causal or prescriptive chains. The added evidence is used as corroboration of existing foundational Claims, not as permission to infer individualized outcomes. Foundational physiology, molecular biology and ecology sources are descriptive; medical slices remain bounded against diagnosis, prescription and treatment instructions.

## Applicability and uncertainty

Medical/health material is explicitly educational/reference-only. Individual applicability requires additional context. Public-health surveillance is not treated as individual diagnosis or a live directive. Environmental biology and marine biology remain descriptive rather than operational. This preserves the distinction between source support and applicability.

## Cross-domain linkage

P9 adds no new cross-slice Relation. This is intentional: evidence maturation does not justify manufacturing graph edges. Existing linkage remains the authoritative current baseline and its audit is synchronized to 4457 corpus records.

## Findings / debt disposition

1. **P9-EVIDENCE-001 — CLOSED:** independent second-source coverage added to all eight selected slices that required maturation.
2. **P9-REFERENCE-001 — CLOSED:** all new Evidence Use claim/source references resolve and pass Reference CI.
3. **P9-COVERAGE-001 — CLOSED:** corpus coverage and cross-slice audit synchronized to 4457 records.
4. **P9-TEST-CONTRACT-001 — CLOSED:** dedicated slice tests now encode the 13-record matured topology.
5. **P9-DOC-001 — CLOSED:** matured-slice READMEs synchronized to the 2-source / 6-evidence topology.
6. **P9-HUMAN-001 — OPEN FOR NEXT STAGE:** Human View/adversarial review remains required before P9 can become CLEAN. Green CI does not close this requirement.

## Conclusion

No blocking substantive evidence/provenance debt was identified in the P9 maturation delta. The evidence additions are appropriately bounded as corroboration, and the corpus remains structurally synchronized. The next mandatory stage is a dedicated Human View/adversarial safety audit across all ten selected Life & Health slices, followed by debt closure and re-audit.

**Epistemic boundary:** source identity, provenance, conformance and CI establish traceability and structural validity; they do not by themselves establish scientific truth or individual applicability.
